{
  "id": 11849231,
  "title": "Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals",
  "url": "https://urgent.news/2026/10/04/better-state-street-healthcare-etf-xbis-biotech-focus-vs-xph",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-04T04:50:57.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/10/04/better-state-street-healthcare-etf-xbi-s-biotech-focus-vs-xph-targeting-pharmaceuticals/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "When choosing between the State Street SPDR S&P Biotech ETF (XBI) and the State Street SPDR S&P Pharmaceuticals ETF (XPH), investors must weigh their risk tolerance against their desire for sector specificity. Both funds provide concentrated exposure to distinct healthcare sub-sectors within the industry.\n\nBiotechnology stocks are notorious for their high-growth potential but also exhibit considerable price fluctuations. On the other hand, pharmaceutical companies generally offer a more stable investment option for those seeking healthcare exposure without the intense volatility typically associated with biotech firms still in early-stage clinical research.\n\nTo assess the risk profile of each ETF, analysts often examine the beta coefficient, which quantifies price volatility relative to the S&P 500. Beta is derived from analyzing monthly returns over the fund's history, typically spanning up to five years. For instance, over the past year, XBI has delivered a total return of 37.17%, while XPH has returned 29.60%. Both funds distribute dividends based on their trailing-12-month earnings.",
  "summary": "XPH delivered 19% higher returns over five years despite half the volatility. XBI's 165 holdings offer broader exposure but with a 53% maximum drawdown.",
  "key_points": [
    "XBI focuses on biotech stocks with high-growth potential and volatility",
    "XPH targets pharmaceutical companies for more stable healthcare exposure",
    "Beta coefficient measures price volatility relative to S&P 500"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals",
        "url": "https://urgent.news/2026/10/04/better-state-street-healthcare-etf-xbis-biotech-focus-vs-xph-11856826",
        "published": "2026-10-04T05:10:57.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}